Allergan Enhances Its Board With the Addition of Leading Ophthalmologist.Business Editors & Health/Medical Writers NOTE TO MEDIA: Multimedia assets available IRVINE, Calif.--(BUSINESS WIRE)--July 31, 2002 Allergan, Inc. (NYSE NYSE See: New York Stock Exchange :AGN AGN Again (Amateur Radio) AGN Active Galactic Nucleus AGN Acute Glomerulonephritis AGN Accountants Global Network AGN Air Gabon (ICAO code) ) today announced that Stephen J. Ryan, M.D. will join the company's Board of Directors on September 23, 2002. Dr. Ryan, an internationally recognized expert in the field of retinal diseases and ocular trauma, is the Dean of the Keck School of Medicine and Senior Vice President for Medical Care of the University of Southern California The U.S. News & World Report ranked USC 27th among all universities in the United States in its 2008 ranking of "America's Best Colleges", also designating it as one of the "most selective universities" for admitting 8,634 of the almost 34,000 who applied for freshman admission as well as President of the Doheny Eye Institute and Grace and Emery Beardsley Professor of Ophthalmology. "Dr. Ryan's experience as a leading ophthalmologist ophthalmologist /oph·thal·mol·o·gist/ (of?thal-mol´ah-jist) a physician who specializes in ophthalmology. oph·thal·mol·o·gist n. A physician who specializes in ophthalmology. and his instrumental role in building the Keck School of Medicine into one of the leading medical schools in the country brings a new dimension and perspective to our Board of Directors," said David E.I. Pyott, Chairman, President and Chief Executive Officer of Allergan. "He is well respected within the medical and academic communities and is an outstanding addition to a board that prides itself on having the breadth and depth of experience necessary to achieve continued success in our ever-changing global marketplace." Dr. Ryan is a Member of the Institute of Medicine of the National Academy of Sciences. In 2002 he was appointed as a member of the National Academies Committee on the Organizational Structure of the National Institutes of Health. He is a member and past President of numerous ophthalmologic organizations such as the Association of University Professors of Ophthalmology and the Macula Society. He is the founding President of the Alliance for Eye and Vision Research (AEVR). Dr. Ryan was awarded his M.D. from The Johns Hopkins University School of Medicine The Johns Hopkins University School of Medicine, located in Baltimore, Maryland, USA, is a highly regarded medical school and biomedical research institute in the United States. and completed his residency and chief residency at the Wilmer Ophthalmologic Institute at Johns Hopkins, where he subsequently was Assistant and Associate Professor of Ophthalmology. He completed a fellowship in ophthalmic pathology at the Armed Forces Institute of Pathology Armed Forces Institute of Pathology A section of the US military which provides consultations, reference atlases and educational programs for pathologists . His numerous awards include the Louis B. Mayer Noun 1. Louis B. Mayer - United States filmmaker (born in Russia) who founded his own film company and later merged with Samuel Goldwyn (1885-1957) Louis Burt Mayer, Mayer Scholar Award from Research to Prevent Blindness, Inc., The Johns Hopkins University Johns Hopkins University, mainly at Baltimore, Md. Johns Hopkins in 1867 had a group of his associates incorporated as the trustees of a university and a hospital, endowing each with $3.5 million. Daniel C. Society of Scholars, the American Academy of Ophthalmology's Senior Honor Award, and the Fight for Sight/Mildred Weisenfeld Lifetime Research Achievement Award. He has authored over 250 publications in the scientific literature and has delivered over 20 named/memorial lectures. Forward-Looking Statements Statements regarding future plans, forecasts, and events are "forward-looking statements." These statements are based on current expectations and intentions only. If underlying assumptions prove inaccurate, or unknown risks or uncertainties materialize, actual results could vary materially from the company's expectations. Information concerning risk factors can be found in press releases issued by Allergan as well as Allergan's public periodic filings with the Securities and Exchange Commission, including the discussion under the heading "Certain Factors and Trends Affecting Allergan and Its Businesses" in Allergan's 2001 Annual Report on Form 10-K Form 10-K A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information. Form 10-K See 10-K. and Form 10-Q for the quarter ended March 29, 2002. Allergan's filings are available publicly and upon request from Allergan's Investor Relations Department: 714/246-4636 or www.allergan.com. About Allergan, Inc. Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care, neuromodulator and skin care markets that deliver value to our customers, satisfy unmet medical needs, and improve patients' lives. Note: A Photo is available at URL URL in full Uniform Resource Locator Address of a resource on the Internet. The resource can be any type of file stored on a server, such as a Web page, a text file, a graphics file, or an application program. : http://www.businesswire.com/cgi-bin/photo.cgi?pw.073102/bb3 |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion